Horizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg ... - MarketWatch (press release)

Horizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg ... MarketWatch (press release) About DUEXIS DUEXIS, a proprietary single-tablet combination of the NSAID ibuprofen and the histamine H2-receptor antagonist famotidine, is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the ... and more »

ACR: Arthritis Patients Seek Alternative Treatments - MedPage Today

ACR: Arthritis Patients Seek Alternative Treatments MedPage Today CHICAGO -- Rheumatoid arthritis patients will try almost anything to relieve symptoms -- including special jewelry, household oils and even homemade concoctions -- researchers reported here. ... and more »

Will You Get These Diseases in 2012? Big Pharma Hopes So. - Food Consumer

Will You Get These Diseases in 2012? Big Pharma Hopes So. Food Consumer Rheumatoid arthritis is a serious and dangerous disease. But so are Pharma's immune suppressing biologic drugs like Remicade, Enbrel and Humira which are pushed to treat it. While RA attacks the body's own tissues, leading to inflammation of the joints ... and more »

Amyloidosis has a variety of ophthalmological manifestations - OSN SuperSite

OSN SuperSite

Amyloidosis has a variety of ophthalmological manifestations OSN SuperSite The disease may be primary, ie, idiopathic, as in primary systemic amyloidosis, or secondary, as in reactive amyloidosis in a patient with chronic rheumatoid arthritis or tuberculosis. Ophthalmologic involvement in amyloidosis may have important ... and more »